Director/PDMR Shareholding (3308Z)
January 12 2011 - 5:13AM
UK Regulatory
TIDMHIK
RNS Number : 3308Z
Hikma Pharmaceuticals Plc
12 January 2011
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters
State whether the notification
relates to (i) a transaction
notified in accordance with
DTR 3.1.2 R, (ii) a disclosure
made in accordance with LR
9.8.6R(1) or (iii) a
disclosure made in accordance
with section 793 of the
Name of the Issuer: Companies Act (2006): DTR
1. Hikma Pharmaceuticals PLC 2. 3.1.2 R
State whether notification
Name of person discharging relates to a person connected
managerial with a person discharging
responsibilities/director: managerial responsibilities/
Samih Darwazah, Said director named in 3 and
Darwazah, Mazen Darwazah identify the connected person:
3. and Ali Al-Husry 4. Yes: Darhold Limited
--------------------------- ---------------- -------------------------------
Indicate whether the
notification is in respect
of a holding of the person
referred to in 3 or 4 Description of shares
above or in respect of a (including class), debentures
non-beneficial interest: or derivatives or financial
Beneficial interest instruments relating to
5. Darhold Limited 6. shares: Ordinary Shares
--------------------------- ---------------- -------------------------------
State the
nature of the
transaction:
The
transaction
comprises the
cancellation
of a variable
forward sale
by Darhold of
up to
1,500,000
Ordinary
Shares. In
connection
with such
cancellation:
(a) 1,500,000
Ordinary
Shares
previously
lent by
Darhold will
be returned;
and (b)
2,000,000
Ordinary
Name of registered Shares
shareholders(s) and, if previously
more than one, the number pledged by
of shares held by each of Darhold will
them: BNP Paribas be released
Securities Services from such
account for an on behalf pledge
7. of Credit Suisse AG 8. arrangements.
--------------------------- ---------------- -------------------------------
Percentage of issued class
acquired (treasury shares
Number of shares, of that class should not
debentures or financial be taken into account when
instruments relating to calculating percentage):
9. shares acquired: N/A 10. N/A
--------------------------- ---------------- -------------------------------
Percentage of issued class
disposed (treasury shares
Number of shares, of that class should not
debentures or financial be taken into account when
instruments relating to calculating percentage):
11. shares disposed: N/A 12. N/A
--------------------------- ---------------- -------------------------------
Price per share or value
of transaction: Date and place of transaction:
13. N/A 14. London, 12 January 2011
--------------------------- ---------------- -------------------------------
Total holding following
notification and total
percentage holding
following notification
(any treasury shares
should not be taken into
account when calculating Date issuer informed of
percentage): 57,183,028 transaction:
15. (29.56%) 16. 12 January 2011
--------------------------- ---------------- -------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer complete the following boxes
------------------------------------------------------------------------------
Period during which
or date on which
17. Date of grant 18. exercisable
-------------------- ---------------- --------------------
Description of
Total amount paid shares or
(if any) for grant debentures involved
19. of the option 20. (class and number)
-------------------- ---------------- --------------------
Exercise price (if
fixed at time of Total number of
grant) or shares or
indication that debentures over
price is to be which options held
fixed at the time following
21. of exercise 22. notification
-------------------- ---------------- --------------------
Name of contact and
Any additional telephone number
23. information 24. for queries
-------------------- ---------------- --------------------
Name of authorised official or issuer responsible for making
notification
Henry Knowles, Company Secretary, Hikma Pharmaceuticals PLC
Date of notification: 12 January 2011
Notes:
This form is intended for use by an issuer to make a RIS
notification required by DTR 3.1.4
(1) An issuer making a notification in respect of a transaction
relating to the shares or debentures of the issuer should complete
boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative
relating the shares of the issuer should complete boxes 1 to 4, 6,
8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options
granted to a director/person discharging managerial
responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial
instrument relating to the shares of the issuer (other than a
debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16,
23 and 24
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBGGDBDBBBGBD
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
